XML 20 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Interim Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Current Assets:      
Cash and cash equivalents $ 4,360 $ 10,670 $ 1,689
Restricted cash 262 273 85
Inventory, net 1,059  
Restricted deposit     184
Account receivables 386 40 28
Other receivables and prepaid expenses 651 579 482
Total current assets 6,718 11,562 2,468
Long term deposit 28  
Property and equipment, net 144 112 128
Right-of-use asset 659 776 911
Intangible asset 294  
Goodwill 268  
Investment in marketable securities 80 108 59
Total non-current assets 1,473 996 1,098
Total assets 8,191 12,558 3,566
Current liabilities:      
Right of use liability 177 138 129
Bank overdraft and short-term loans 195  
Trade payables 749 635 381
Other payables 390  
Account payables 596 453 400
Derivatives 28 2 1
Total current liabilities 2,135 1,228 911
Long term loans 86  
Deferred tax liabilities 68  
Long term right of use liability 368 473 579
Total non-current liabilities 522 473 579
COMMITMENTS AND CONTINGENCIES  
Total liabilities 2,657 1,701 1,490
Stockholders’ equity:      
Common stock value 1 [1] 1 [1] 7 [2]
Additional paid-in capital 57,238 [1] 56,453 [1] 37,164
Accumulated other comprehensive loss (584) (406) (424)
Accumulated deficit (51,121) (45,191) (34,671)
Total stockholders’ equity 5,534 10,857 2,076
Total liabilities and stockholders’ equity $ 8,191 12,558 $ 3,566
Previously Reported [Member]      
Current Assets:      
Cash and cash equivalents   10,670  
Restricted cash   273  
Restricted deposit    
Account receivables   40  
Other receivables and prepaid expenses   579  
Total current assets   11,562  
Property and equipment, net   112  
Right-of-use asset   776  
Investment in marketable securities   108  
Total non-current assets   996  
Total assets   12,558  
Current liabilities:      
Right of use liability   138  
Trade payables   635  
Account payables   453  
Derivatives   2  
Total current liabilities   1,228  
Long term right of use liability   473  
Total non-current liabilities   473  
COMMITMENTS AND CONTINGENCIES    
Total liabilities   1,701  
Stockholders’ equity:      
Common stock value [2]   24  
Additional paid-in capital   56,430  
Accumulated other comprehensive loss   (406)  
Accumulated deficit   (45,191)  
Total stockholders’ equity   10,857  
Total liabilities and stockholders’ equity   $ 12,558  
[1] Prior period results have been retroactively adjusted to reflect the 1-for-25 reverse stock split of the issued and outstanding shares of common stock that was made on December 8, 2022. See notes 9b.
[2] Prior period results have been retroactively adjusted to reflect the 1:25 reverse stock split of the issued and outstanding shares of common stock that was made on December 8, 2022. See notes 16b.